Colgate-Palmolive (NYSE:CL) Shares Unloaded Rep. Lisa C. McClain

Representative Lisa C. McClain (R-Michigan) recently sold shares of Colgate-Palmolive Company (NYSE:CL). In a filing disclosed on August 13th, the Representative disclosed that they had sold between $1,001 and $15,000 in Colgate-Palmolive stock on June 24th. The trade occurred in the Representative’s “CHARLES SCHWAB BROKERAGE ACCOUNT 924” account.

Representative Lisa C. McClain also recently made the following trade(s):

  • Sold $1,001 – $15,000 in shares of Autoliv (NYSE:ALV) on 8/4/2025.
  • Sold $1,001 – $15,000 in shares of Amazon.com (NASDAQ:AMZN) on 8/4/2025.
  • Sold $1,001 – $15,000 in shares of Applied Materials (NASDAQ:AMAT) on 8/4/2025.
  • Sold $1,001 – $15,000 in shares of Arthur J. Gallagher & Co. (NYSE:AJG) on 8/4/2025.
  • Sold $1,001 – $15,000 in shares of SAP (NYSE:SAP) on 7/22/2025.
  • Purchased $1,001 – $15,000 in shares of XPO (NYSE:XPO) on 7/22/2025.
  • Purchased $1,001 – $15,000 in shares of Lithia Motors (NYSE:LAD) on 7/22/2025.
  • Sold $1,001 – $15,000 in shares of Sanofi (NASDAQ:SNY) on 7/22/2025.
  • Sold $1,001 – $15,000 in shares of Waters (NYSE:WAT) on 7/22/2025.
  • Purchased $1,001 – $15,000 in shares of Group 1 Automotive (NYSE:GPI) on 7/22/2025.

Colgate-Palmolive Trading Down 0.9%

CL stock opened at $84.30 on Tuesday. The company has a debt-to-equity ratio of 6.79, a current ratio of 0.89 and a quick ratio of 0.57. The company has a fifty day moving average price of $88.07 and a two-hundred day moving average price of $89.98. Colgate-Palmolive Company has a one year low of $82.40 and a one year high of $109.30. The stock has a market cap of $68.13 billion, a price-to-earnings ratio of 23.68, a price-to-earnings-growth ratio of 4.42 and a beta of 0.35.

Colgate-Palmolive (NYSE:CLGet Free Report) last released its quarterly earnings data on Friday, August 1st. The company reported $0.92 EPS for the quarter, topping analysts’ consensus estimates of $0.89 by $0.03. Colgate-Palmolive had a net margin of 14.55% and a return on equity of 377.63%. The firm had revenue of $5.11 billion during the quarter, compared to analysts’ expectations of $5.03 billion. During the same period in the previous year, the business posted $0.91 earnings per share. The company’s revenue for the quarter was up 1.0% compared to the same quarter last year. Equities analysts anticipate that Colgate-Palmolive Company will post 3.75 EPS for the current year.

Colgate-Palmolive Announces Dividend

The business also recently disclosed a quarterly dividend, which was paid on Friday, August 15th. Shareholders of record on Friday, July 18th were given a dividend of $0.52 per share. This represents a $2.08 dividend on an annualized basis and a yield of 2.5%. The ex-dividend date of this dividend was Friday, July 18th. Colgate-Palmolive’s payout ratio is 58.43%.

Analyst Ratings Changes

CL has been the subject of a number of research analyst reports. Morgan Stanley reduced their price objective on shares of Colgate-Palmolive from $104.00 to $96.00 and set an “overweight” rating for the company in a research report on Monday, August 4th. UBS Group reduced their price objective on shares of Colgate-Palmolive from $109.00 to $106.00 and set a “buy” rating for the company in a research report on Thursday, July 17th. JPMorgan Chase & Co. reduced their price objective on shares of Colgate-Palmolive from $99.00 to $95.00 and set an “overweight” rating for the company in a research report on Monday, August 4th. Citigroup dropped their target price on Colgate-Palmolive from $108.00 to $105.00 and set a “buy” rating for the company in a report on Monday, August 4th. Finally, Wells Fargo & Company dropped their target price on Colgate-Palmolive from $88.00 to $83.00 and set an “underweight” rating for the company in a report on Monday, August 4th. One equities research analyst has rated the stock with a sell rating, five have assigned a hold rating and seven have given a buy rating to the company. According to data from MarketBeat.com, Colgate-Palmolive currently has an average rating of “Hold” and a consensus target price of $98.92.

Get Our Latest Research Report on Colgate-Palmolive

Institutional Inflows and Outflows

A number of hedge funds and other institutional investors have recently bought and sold shares of the stock. Norges Bank acquired a new position in Colgate-Palmolive during the second quarter worth about $960,390,000. Price T Rowe Associates Inc. MD raised its stake in Colgate-Palmolive by 18.3% during the first quarter. Price T Rowe Associates Inc. MD now owns 34,009,078 shares of the company’s stock worth $3,186,651,000 after acquiring an additional 5,269,140 shares in the last quarter. Schroder Investment Management Group raised its stake in Colgate-Palmolive by 242.3% during the second quarter. Schroder Investment Management Group now owns 5,324,115 shares of the company’s stock worth $483,962,000 after acquiring an additional 3,768,784 shares in the last quarter. Nuveen LLC acquired a new position in Colgate-Palmolive during the first quarter worth about $217,593,000. Finally, Goldman Sachs Group Inc. raised its stake in Colgate-Palmolive by 34.5% during the first quarter. Goldman Sachs Group Inc. now owns 7,980,387 shares of the company’s stock worth $747,762,000 after acquiring an additional 2,045,191 shares in the last quarter. Institutional investors and hedge funds own 80.41% of the company’s stock.

About Representative McClain

Lisa McClain (Republican Party) is a member of the U.S. House, representing Michigan’s 9th Congressional District. She assumed office on January 3, 2023. Her current term ends on January 3, 2027.

McClain (Republican Party) is running for re-election to the U.S. House to represent Michigan’s 9th Congressional District. She declared candidacy for the 2026 election.

Lisa McClain lives in Romeo, Michigan. McClain earned a bachelor’s degree in business administration from Northwood University. Her career experience includes founding and working as the president of North End Support Team.

Colgate-Palmolive Company Profile

(Get Free Report)

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.

Further Reading

Receive News & Ratings for Colgate-Palmolive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive and related companies with MarketBeat.com's FREE daily email newsletter.